IP Library Granted Patent US 8,119,410
Granted Patent B2
US 8,119,410 · App. 12/946,722 · Granted Feb 21, 2012

Apoptosis modulator Bcl-B and methods for making and using same

Assignee: Sanford-Burnham Medical Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,410
App. No.
12/946,722
Granted
Feb 21, 2012
Kind
B2
Abstract

A novel human member of the Bcl-2 family Bcl-B has been identified, which is closest in amino-acid sequence homology to the Boo (Diva) protein. The Bcl-B protein is widely expressed in adult human tissues. The Bcl-B protein modulates apoptosis. Bcl-B also binds Bcl-2, BCl-XL, and Bax but not Bak. Bcl-B displays a unique pattern of selectivity for binding and regulating the function of other members of the Bcl-2 family.

Claims (25)

1. An isolated or recombinant polypeptide comprising a sequence having at least about 99% identity to SEQ ID NO:2.

2. An isolated or recombinant polypeptide comprising at least 200 amino acids of SEQ ID NO:2.

3. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide contains a transmembrane domain.

4. The isolated or recombinant polypeptide of claim 1 , wherein the transmembrane domain comprises a mitochondrial protein or a Bcl-2 protein family member transmembrane domain.

5. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide has an activity selected from modulating apoptosis, homodimerization, heteromerization, binding to Bcl-2, Bcl-XL or Bax, forming a membrane channel, associating with mitochondria, and immunogenicity.

6. The isolated or recombinant polypeptide of claim 5 , wherein the polypeptide modulates apoptosis in a bacterial, plant, insect, mammalian or yeast cell.

7. The isolated or recombinant polypeptide of claim 6 , wherein the mammalian cell is a human cell selected from heart, brain, lung, kidney, liver, pancreas, spleen, thymus, colon, leukocyte, small intestine, testis, prostate and ovarian cell.

8. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide inhibits Bax mediated apoptosis.

9. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide does not detectably inhibit Bak mediated apoptosis.

10. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide contains one or more BH1, BH2, BH3 or BH4 domains.

11. The isolated or recombinant polypeptide of claim 1 , wherein the polypeptide is attached to a substrate.

12. A composition comprising a plurality of polypeptides attached to a substrate, wherein one or more of the polypeptide comprises the isolated or recombinant polypeptide of claim 1 .

13. The composition of claim 12 , wherein the polypeptides are attached at defined positions of the substrate.

14. An isolated or recombinant polypeptide comprising a sequence having 100% identity to SEQ ID NO:2.

15. The isolated or recombinant polypeptide of claim 14 , wherein the polypeptide contains a transmembrane domain.

16. The isolated or recombinant polypeptide of claim 14 , wherein the transmembrane domain comprises a mitochondrial protein or a Bcl-2 protein family member transmembrane domain.

17. The isolated or recombinant polypeptide of claim 14 , wherein the polypeptide has an activity selected from modulating apoptosis, homodimerization, heteromerization, binding to Bcl-2, Bcl-XL or Bax, forming a membrane channel, associating with mitochondria, and immunogenicity.

18. The isolated or recombinant polypeptide of claim 17 , wherein the polypeptide modulates apoptosis in a bacterial, plant, insect, mammalian or yeast cell.

19. The isolated or recombinant polypeptide of claim 18 , wherein the mammalian cell is a human cell selected from heart, brain, lung, kidney, liver, pancreas, spleen, thymus, colon, leukocyte, small intestine, testis, prostate and ovarian cell.

20. The isolated or recombinant polypeptide of claim 14 , wherein the polypeptide inhibits Bax mediated apoptosis.

21. The isolated or recombinant polypeptide of claim 14 , wherein the polypeptide does not detectably inhibit Bak mediated apoptosis.

22. The isolated or recombinant polypeptide of claim 14 , wherein the polypeptide contains one or more BH1, BH2, BH3 or BH4 domains.

23. The isolated or recombinant polypeptide of claim 14 , wherein the polypeptide is attached to a substrate.

24. A composition comprising a plurality of polypeptides attached to a substrate, wherein one or more of the polypeptide comprises the isolated or recombinant polypeptide of claim 14 .

25. The composition of claim 24 , wherein the polypeptides are attached at defined positions of the substrate.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 13, 2019
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 050997/0427 →
Continuity (4)
Continuation 12426479 · Apr 20, 2009
Division 10071174 · Feb 7, 2002
Provisional Application 60267166 · Feb 7, 2001
Related Publication 20110190168A1 · Aug 4, 2011